Mechanism of death in patients with the automatic implantable cardioverter defibrillator

R. M. Luceri, S. M. Habal, Agustin Castellanos, Richard J Thurer, R. S. Waters, S. L. Brownstein

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Fifty patients underwent primary implantation of an automatic implantable cardioverter defibrillator between August 1983 and April 1988 and were entered into a long-term surveillance program. There were a total of 14 deaths (28%) in the entire group occurring at a mean of 8.7 months postimplantation. Eleven deaths were cardiac and three were noncardiac (two pneumonia, one leukemia). The group of deceased patients were similar to the survivors in all respects except for a statistically lower ejection fraction (23% vs 32%) at the time of implantation. In addition, 13/14 (93%) of the deceased patients experienced at least one appropriate AICD discharge at a mean of 4.5 months post implantation. Recorded ECGs at the time of death revealed that most of the sudden deaths were due to electromechanical dissociation and not to AICD-treatable arrhythmias. These data suggest therefore that death in AICD patients is usually cardiac, due primarily to low ejection fraction and occurs in patients who have previously received AICD discharges.

Original languageEnglish
Pages (from-to)2015-2022
Number of pages8
JournalPACE - Pacing and Clinical Electrophysiology
Volume11
Issue number11 II
StatePublished - Dec 1 1988

Fingerprint

Implantable Defibrillators
Sudden Death
Survivors
Cardiac Arrhythmias
Pneumonia
Electrocardiography
Leukemia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Luceri, R. M., Habal, S. M., Castellanos, A., Thurer, R. J., Waters, R. S., & Brownstein, S. L. (1988). Mechanism of death in patients with the automatic implantable cardioverter defibrillator. PACE - Pacing and Clinical Electrophysiology, 11(11 II), 2015-2022.

Mechanism of death in patients with the automatic implantable cardioverter defibrillator. / Luceri, R. M.; Habal, S. M.; Castellanos, Agustin; Thurer, Richard J; Waters, R. S.; Brownstein, S. L.

In: PACE - Pacing and Clinical Electrophysiology, Vol. 11, No. 11 II, 01.12.1988, p. 2015-2022.

Research output: Contribution to journalArticle

Luceri, RM, Habal, SM, Castellanos, A, Thurer, RJ, Waters, RS & Brownstein, SL 1988, 'Mechanism of death in patients with the automatic implantable cardioverter defibrillator', PACE - Pacing and Clinical Electrophysiology, vol. 11, no. 11 II, pp. 2015-2022.
Luceri RM, Habal SM, Castellanos A, Thurer RJ, Waters RS, Brownstein SL. Mechanism of death in patients with the automatic implantable cardioverter defibrillator. PACE - Pacing and Clinical Electrophysiology. 1988 Dec 1;11(11 II):2015-2022.
Luceri, R. M. ; Habal, S. M. ; Castellanos, Agustin ; Thurer, Richard J ; Waters, R. S. ; Brownstein, S. L. / Mechanism of death in patients with the automatic implantable cardioverter defibrillator. In: PACE - Pacing and Clinical Electrophysiology. 1988 ; Vol. 11, No. 11 II. pp. 2015-2022.
@article{b1e881e524844382880b170550ef49e9,
title = "Mechanism of death in patients with the automatic implantable cardioverter defibrillator",
abstract = "Fifty patients underwent primary implantation of an automatic implantable cardioverter defibrillator between August 1983 and April 1988 and were entered into a long-term surveillance program. There were a total of 14 deaths (28{\%}) in the entire group occurring at a mean of 8.7 months postimplantation. Eleven deaths were cardiac and three were noncardiac (two pneumonia, one leukemia). The group of deceased patients were similar to the survivors in all respects except for a statistically lower ejection fraction (23{\%} vs 32{\%}) at the time of implantation. In addition, 13/14 (93{\%}) of the deceased patients experienced at least one appropriate AICD discharge at a mean of 4.5 months post implantation. Recorded ECGs at the time of death revealed that most of the sudden deaths were due to electromechanical dissociation and not to AICD-treatable arrhythmias. These data suggest therefore that death in AICD patients is usually cardiac, due primarily to low ejection fraction and occurs in patients who have previously received AICD discharges.",
author = "Luceri, {R. M.} and Habal, {S. M.} and Agustin Castellanos and Thurer, {Richard J} and Waters, {R. S.} and Brownstein, {S. L.}",
year = "1988",
month = "12",
day = "1",
language = "English",
volume = "11",
pages = "2015--2022",
journal = "PACE - Pacing and Clinical Electrophysiology",
issn = "0147-8389",
publisher = "Wiley-Blackwell",
number = "11 II",

}

TY - JOUR

T1 - Mechanism of death in patients with the automatic implantable cardioverter defibrillator

AU - Luceri, R. M.

AU - Habal, S. M.

AU - Castellanos, Agustin

AU - Thurer, Richard J

AU - Waters, R. S.

AU - Brownstein, S. L.

PY - 1988/12/1

Y1 - 1988/12/1

N2 - Fifty patients underwent primary implantation of an automatic implantable cardioverter defibrillator between August 1983 and April 1988 and were entered into a long-term surveillance program. There were a total of 14 deaths (28%) in the entire group occurring at a mean of 8.7 months postimplantation. Eleven deaths were cardiac and three were noncardiac (two pneumonia, one leukemia). The group of deceased patients were similar to the survivors in all respects except for a statistically lower ejection fraction (23% vs 32%) at the time of implantation. In addition, 13/14 (93%) of the deceased patients experienced at least one appropriate AICD discharge at a mean of 4.5 months post implantation. Recorded ECGs at the time of death revealed that most of the sudden deaths were due to electromechanical dissociation and not to AICD-treatable arrhythmias. These data suggest therefore that death in AICD patients is usually cardiac, due primarily to low ejection fraction and occurs in patients who have previously received AICD discharges.

AB - Fifty patients underwent primary implantation of an automatic implantable cardioverter defibrillator between August 1983 and April 1988 and were entered into a long-term surveillance program. There were a total of 14 deaths (28%) in the entire group occurring at a mean of 8.7 months postimplantation. Eleven deaths were cardiac and three were noncardiac (two pneumonia, one leukemia). The group of deceased patients were similar to the survivors in all respects except for a statistically lower ejection fraction (23% vs 32%) at the time of implantation. In addition, 13/14 (93%) of the deceased patients experienced at least one appropriate AICD discharge at a mean of 4.5 months post implantation. Recorded ECGs at the time of death revealed that most of the sudden deaths were due to electromechanical dissociation and not to AICD-treatable arrhythmias. These data suggest therefore that death in AICD patients is usually cardiac, due primarily to low ejection fraction and occurs in patients who have previously received AICD discharges.

UR - http://www.scopus.com/inward/record.url?scp=0024208601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024208601&partnerID=8YFLogxK

M3 - Article

C2 - 2463581

AN - SCOPUS:0024208601

VL - 11

SP - 2015

EP - 2022

JO - PACE - Pacing and Clinical Electrophysiology

JF - PACE - Pacing and Clinical Electrophysiology

SN - 0147-8389

IS - 11 II

ER -